Janet L. Gross

Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

R. V. J. CHARI, B. Martell, Janet L. Gross et al. · PubMed · 1992 · 266 citations

Medicinal Chemistry, Active Drug, Polymer-drug Conjugate +12

Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.

Janet L. Gross, David Moscatelli, D B Rifkin · Proceedings of the National Academy of Sciences · 1983 · 261 citations · Full text

Immunology, Cell Proliferation, Inflammation +18

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

Shingo Takano, Stephen Gately, Mary E. Neville et al. · PubMed · 1994 · 132 citations

Endothelial Cell Binding, Pathology, Pharmacotherapy +20

Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients.

Luís Henrique Santos Canani, Fernando Gerchman, Janet L. Gross · Diabetes · 1999 · 109 citations

Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library.

A Yayon, David Aviezer, Michal Safran et al. · Proceedings of the National Academy of Sciences · 1993 · 106 citations · Full text

Peptide Engineering, Immunology, Pathology +19